Nurse Practitioner in Venice, CA Accepting Medicare

13 Nurse Practitioner nurses found. Showing 1 - 13

Alain Broulard, Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 1122 Garfield Ave, Venice, CA 90291 Phone: 818-384-0927

Elisabeth Helen Cederblom, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636

Bridget Kelleher, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636

Danielle Sinkford, N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636

Nancy Marie Pierre-paul, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636

Janet Chaidez, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636

Mrs. Ligaya Docena Scarlett, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636    Fax: 310-664-7913

Dr. Ebony Nicole Funches, DNP, FNP-C, AG-ACNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636    Fax: 310-392-6642

John Eric Singidas, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636    Fax: 310-392-6642

Amy Asheroff, NP Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636    Fax: 310-392-6642

Amber Fonteyne, N.P. Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 340 Main St # 140a, Venice, CA 90291 Phone: 310-310-6380

Ms. Pippa Ann Stewart, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636

Nicole Marie Eggold, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 526 Brooks Ave, 1/2, Venice, CA 90291 Phone: 949-547-1945

News Archive

Verax Platelet PGD test receives FDA clearance

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has cleared the Verax Platelet PGD® test as a quality control test to detect bacterial contamination in whole blood-derived, pooled platelets prior to transfusion. Fenwal is the exclusive global distributor of the test, which was developed by Verax Biomedical of Worcester, Mass.

IDIBELL and IDIPAZ scientists identify epigenetic alterations in CVID

Researchers of the Chromatin and Disease Group from the Bellvitge Biomedical Research Institute and La Paz Hospital have identified epigenetic alterations in Common Variable Immunodeficiency (CVID), the most common primary immunodeficiency, using as a starting point genetically identical monozygotic twins discordant for the disease.

NAA joins with organizations worldwide to raise awareness about autism

The National Autism Association joins with organizations worldwide in recognizing April as Autism Awareness month. With one in 110 children now diagnosed with autism, and autism mortality rates doubling that of the general population, NAA is once again calling upon legislators and government health agencies to declare autism a national health emergency.

FDA accepts Teva's NDA for Quartette oral contraceptive

Teva Women's Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the U.S. Food and Drug Administration has accepted for filing its New Drug Application for Quartette (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets).

Blood cancer drug trial results questioned by FDA

U.S. drug reviewers might limit the use of a Seattle Genetics Inc's experimental blood cancer drug due to the narrow scope of its clinical trials. According to papers released Tuesday by the Food and Drug Administration (FDA), it requests an advisory panel to consider the drug, under the proposed trade name Adcetris known chemically as brentuximab vedotin, for use in previously treated patients with Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL).

Read more Medical News

› Verified 9 days ago